Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Vaccine Contract Manufacturing is estimated at US$4.2 Billion in 2023 and is projected to reach US$7 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Attenuated Vaccine Contract Manufacturing segment, which is expected to reach US$2.6 Billion by 2030 with a CAGR of a 7.3%. The Inactivated Vaccine Contract Manufacturing segment is also set to grow at 7% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.1 Billion in 2023, and China, forecasted to grow at an impressive 11.5% CAGR to reach $1.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Vaccine Contract Manufacturing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vaccine Contract Manufacturing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Vaccine Contract Manufacturing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Ajinomoto Althea, Inc., Albany Molecular Research, Inc., Catalent, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 34 Featured):
- Ajinomoto Althea, Inc.
- Albany Molecular Research, Inc.
- Catalent, Inc.
- Cobra Bio
- Cytovance Biologics
- Fujifilm Diosynth Biotechnologies U.S.A., Inc.
- Icon plc
- IDT Biologika
- KBI Biopharma
- Lonza
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 274 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $4.2 Billion |
| Forecasted Market Value (USD) by 2030 | $7 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/u3a9fn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
